{"id":"https://genegraph.clinicalgenome.org/r/85148e78-2ec8-4a4c-8f60-0cd45336d5cbv1.0","type":"EvidenceStrengthAssertion","dc:description":"The *NME5* gene was first reported in relation to primary ciliary dyskinesia in 2020 (Cho et al., PMID: 32185794). The specific disease entity, primary ciliary dyskinesia 48, without situs inversus (MONDO:0031054, OMIM #620032), is one of at least 40 different primary ciliary dyskinesias distinguished by a single monogenic cause. Affected patients have exhibited recurrent sinusitis and bacterial pulmonary infections, pneumonia, bronchiectasis, otitis media with hearing impairment, and respiratory motile cilia with absence of the central microtubular pair and/or other abnormalities of microtubule number. On the other hand, abnormalities of abdominal situs or of the inner and outer dynein arms have been absent. Due to the limited number of case reports available (PMID: 32185794, PMID: 32950024, PMID: 37957793), it is not yet clear whether other primary ciliary dyskinesia-related features such as infertility are present among affected cases. Patient iPSC-derived multiciliated epithelial cells exhibit ciliary beat frequencies that are higher and more variable than control cells, accompanied by impaired mucociliary clearance (PMID: 37296588).\n\nThis curation has scored three suspected disease-causing *NME5* variants (one nonsense and two frameshift), which were reported in the homozygous or compound heterozygous state in three published probands (PMID: 32185794, PMID: 32950024, PMID: 37957793). Two of the variants likely trigger nonsense-mediated decay, while the other is predicted to generate a C-terminally truncated protein product. The molecular mechanism appears to be biallelic loss of function with an autosomal recessive mode of inheritance, characterized in at least some cases by variants predicted to trigger the absence of a gene product. However, the limited number of patients and functional assays available has so far precluded a more thorough analysis of molecular mechanism. Please note that an urgent need remains for additional published case data to establish the spectrum of disease and evaluate the pathogenicity of other emerging variants in this locus.\n\nThis gene-disease association is also supported by abundant biochemical evidence that *NME5* encodes a component of the radial spoke neck, a critical structure within the axoneme of respiratory cilia and sperm flagella (PMID: 21391306, PMID: 25789548, PMID: 22065640, PMID: 12169685, PMID: 14499630). The RSPH1, RSPH4A, and RSPH9 genes encoding other radial spoke components have each been associated with monogenic forms of primary ciliary dyskinesias, all of which similarly present with central microtubule complex and radial spoke defects (PMID: 23993197, PMID: 19200523, PMID: 19200523). Human tissues with the highest levels of *NME5* expression include tissue types known to contain multi-ciliated or flagellated cells, including the testes, fallopian tubes, and lungs (PMID: 23715323). Animal models of *NME5* loss-of-function have been identified in canines (PMID: 31479451) and generated in zebrafish (PMID: 32185794), mice (PMID: 21746835), and *Xenopus* embryos (PMID: 24424412). These models recapitulate features of the human patients such as abnormalities of motility and axonemal organization of respiratory motile cilia, reduced cilia-based flow rate, rhinitis, impaired nasal mucociliary clearance, recurrent bacterial infections, recurrent bronchitis, and bronchiectasis (PMID: 31479451, PMID: 32185794, PMID: 21746835, PMID: 24424412).\n\nIn summary, the evidence linking *NME5* with primary ciliary dyskinesia 48 without situs inversus has reached a classification in the moderate range. Additional genetic evidence from research and diagnostic settings will be required to reach a more definitive gene-disease association. This classification was approved by the ClinGen Motile Ciliopathy GCEP on February 8th, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/85148e78-2ec8-4a4c-8f60-0cd45336d5cb","GCISnapshot":"https://genegraph.clinicalgenome.org/r/00efe110-5916-4da0-92ac-cee8c8b18140","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/00efe110-5916-4da0-92ac-cee8c8b18140_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10102","date":"2024-04-06T02:29:17.618Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/00efe110-5916-4da0-92ac-cee8c8b18140_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10102","date":"2024-02-08T17:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00efe110-5916-4da0-92ac-cee8c8b18140_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20358a85-3e80-4936-beb2-821676d73ca3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a48f6e48-a4f8-4f4c-9564-b6c748817c88","type":"EvidenceLine","dc:description":"NM_003551.3(NME5):c.415del (p.Ile139fs) is a frameshift variant in exon 4 of 6, and is predicted to trigger nonsense-mediated decay or to at least truncate the C-terminal 35% of the protein product. Immunofluorescent staining of patient iPSC-derived respiratory epithelial cells confirms that NME5 is absent from multiciliated cells (PMID: 37296588). Down-scoring has been performed due to the homozygous state of the variant and confirmation of consanguinity, as well as lack of detailed phenotypes and limitations of the genotyping method.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a48f6e48-a4f8-4f4c-9564-b6c748817c88_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32950024","allele":{"id":"https://genegraph.clinicalgenome.org/r/34dbda1c-b715-4eaf-8d4a-6f6f68a4065b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003551.3(NME5):c.415del (p.Ile139TyrfsTer8)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580072815"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/20358a85-3e80-4936-beb2-821676d73ca3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32950024","rdfs:label":"Sahabian_2020_Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":22,"allele":{"id":"https://genegraph.clinicalgenome.org/r/34dbda1c-b715-4eaf-8d4a-6f6f68a4065b"},"detectionMethod":"The primary method of genotyping has not been described in detail, however, confirmation has relied on Sanger sequencing of the NME5 locus.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"The patient has been diagnosed with PCD, with no detailed clinical information provided. Patient iPSC-derived respiratory epithelial cells exhibit cilia with cross-sections with a high frequency of absence of central microtubule pair or an outer microtubule pair, or with other abnormalities of microtubule number. In addition, cIliary beat frequency was higher and more variable than control cells, accompanied by impaired mucociliary clearance (PMID: 37296588). A separate publication (PMID: 37998386) has shown P. aeruginosa infection and an abnormal HSVM result with uncoordinated and circular beating.","phenotypes":["obo:HP_0012260","obo:HP_0011947","obo:HP_0012262"],"previousTesting":false,"previousTestingDescription":"The primary method of genotyping has not been described in detail.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a48f6e48-a4f8-4f4c-9564-b6c748817c88_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/40b9dd8d-2a4f-43d4-a600-f9ee3f4bed0d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08577400-0b69-42e5-a2d2-d889e9433863","type":"EvidenceLine","dc:description":"This is a nonsense variant in exon 6 of 6 with nonsense-mediated decay not predicted, but rather truncation of the C-terminal 10% of the protein. Down-scoring by half has been recommended due to the variant having previously been scored for a separate proband.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08577400-0b69-42e5-a2d2-d889e9433863_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37957793","allele":{"id":"https://genegraph.clinicalgenome.org/r/97e463b7-03c9-4c20-84e9-b0c475a18973","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003551.3(NME5):c.572G>A (p.Trp191Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3424901"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/00c12bcb-ea94-45b3-b1ae-8f0daa9b36e6","type":"EvidenceLine","dc:description":"This is a frameshift variant in exon 5 of 6 with nonsense-mediated decay predicted. Moderate down-scoring has been considered due to the lack of availability of electron microscopy data or other detailed phenotypes for this proband.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00c12bcb-ea94-45b3-b1ae-8f0daa9b36e6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37957793","allele":{"id":"https://genegraph.clinicalgenome.org/r/96e4de82-30c6-4673-872f-b7239d95c56a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003551.3(NME5):c.479_480del (p.Tyr160PhefsTer11)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3424944"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/40b9dd8d-2a4f-43d4-a600-f9ee3f4bed0d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37957793","rdfs:label":"Kim_2023_Patient_10","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":5,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/97e463b7-03c9-4c20-84e9-b0c475a18973"},{"id":"https://genegraph.clinicalgenome.org/r/96e4de82-30c6-4673-872f-b7239d95c56a"}],"detectionMethod":"Genotyping consisted of proband-parent trio whole-exome sequencing to characterize and confirm the compound heterozygous genotype. It is not clear whether confirmation by Sanger sequencing was performed.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"The patient has received a diagnosis of primary ciliary dyskinesia, but is part of a cohort in which detailed phenotypes are not shown for individual probands. Please note that TEM was not performed for this proband.","phenotypes":"obo:HP_0002093","previousTesting":true,"previousTestingDescription":"Previous testing consisted of proband-parent trio whole-exome sequencing to characterize and confirm the compound heterozygous genotype.","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/00c12bcb-ea94-45b3-b1ae-8f0daa9b36e6_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/08577400-0b69-42e5-a2d2-d889e9433863_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.75},{"id":"https://genegraph.clinicalgenome.org/r/019799e0-d38b-4547-adbf-9b29b9ee945e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9b2e6cf-df39-42f8-9592-9e7dc560244e","type":"EvidenceLine","dc:description":"NM_003551.3(NME5):c.572G>A (p.Trp191Ter) is a rare nonsense variant in exon 6 of 6, and is not predicted to trigger nonsense-mediated decay, but rather to truncate the C-terminal 9% of the protein product. Up-scoring has been performed to reflect this predicted impact on the protein product, but has been limited by the homozygous state of the variant and the prediction that NMD will not occur.","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9b2e6cf-df39-42f8-9592-9e7dc560244e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32185794","allele":{"id":"https://genegraph.clinicalgenome.org/r/97e463b7-03c9-4c20-84e9-b0c475a18973"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/019799e0-d38b-4547-adbf-9b29b9ee945e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32185794","rdfs:label":"Cho_2020_Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":38,"allele":{"id":"https://genegraph.clinicalgenome.org/r/97e463b7-03c9-4c20-84e9-b0c475a18973"},"detectionMethod":"Whole-exome sequencing was used to genotype the patient, focused on 44 PCD-causing genes, 24 PCD candidate genes, and 990 ciliome genes. Sanger sequencing of NME5 was used for confirmation.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"The patient has been diagnosed with PCD characterized by radial spoke / central pair defects. She is part of a cohort of patients with non-tuberculous mycobacterial pulmonary infections, has been diagnosed with these infections repeatedly, and has undergone right middle lobectomy.","phenotypes":["obo:HP_0012264","obo:HP_0000388","obo:HP_0002090","obo:HP_0032261","obo:HP_0011108","obo:HP_0000365","obo:HP_0002110"],"previousTesting":true,"previousTestingDescription":"Previous genotpying consisted of whole-exome sequencing focused on 44 PCD-causing genes, 24 PCD candidate genes, and 990 ciliome genes.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d9b2e6cf-df39-42f8-9592-9e7dc560244e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3.75},{"id":"https://genegraph.clinicalgenome.org/r/00efe110-5916-4da0-92ac-cee8c8b18140_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00efe110-5916-4da0-92ac-cee8c8b18140_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/56299d5c-ad20-47ee-9348-dd6ac65659ec","type":"EvidenceLine","dc:description":"Moderate down-scoring was considered appropriate due to the lack of characterization of ciliary morphology as well as the confirmed absence of otitis media in the model animals.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1540912-f1e7-4dec-bef4-4c39e2352d11","type":"Finding","dc:description":"This is a genetically engineered mouse model of biallelic *Nme5* loss. In addition to hydrocephalus with doming of the skull and brain tissue loss (Figure 3), knockout mice also showed nasal exudate accumulation (Figure 4) and spermatogenic abnormalities, especially reduced formation and detachment of flagella (Figure 6). Situs inversus was not observed, consistent with the known human patients. Otitis media was also looked for but not observed.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21746835","rdfs:label":"Genetically engineered Nme5 loss-of-function mouse PCD model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e8c8818b-3798-4275-a8cf-66afc71a8f70","type":"EvidenceLine","dc:description":"Down-scoring has been recommended because the model recapitulates a subset of human patient phenotypes. However, the laterality defect in the model does not have a human equivalent.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/645b409d-52e2-49d1-9ffd-33de0bc33857","type":"Finding","dc:description":"Zebrafish with morpholino-based Nme5 knockdown exhibited small eyes, hydrocephalus, otolith defects in the ear, trunk curvature, and heart looping reversal (Figures 2Aâ€“2H).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32185794","rdfs:label":"nme5 knockdown in zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/18c945d8-8d74-4a31-b629-26bc042b032f","type":"EvidenceLine","dc:description":"Down-scoring has been performed because the model has recapitulated one of the cellular features of human patients harboring NME5 defects but has not been examined for other organ-level phenotypes.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f297939-d7aa-4951-af97-ba6540a1cb9a","type":"Finding","dc:description":"Xenopus embyros with morpholino-based Nme5 knockdown exhibited significantly reduced cilia-based flow rate based upon the movement of latex beads across the epidermis of the embryo (Figure 4 Supplement 2G).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24424412","rdfs:label":"Nme5 knockdown in Xenopus embyros","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ce66633e-276c-41d0-9427-7e5b12a5634c","type":"EvidenceLine","dc:description":"The degree of phenotypic match between the affected animals and the NME5-deficient human patients have led to a recommendation of default scoring. The variant was naturally occurring in Alaskan Malamutes rather than a targeted mutation, and has not been observed in an affected human patient.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c31b1ae5-cc12-40d8-80a6-14cdcf06c019","type":"Finding","dc:description":"Alaskan Malamutes harboring the homozygous variant in NME5 exhibit lack of situs inversus, severe bronchial lung pattern with bronchiectasis (Figure 1), hyperemia of the tracheal mucosa with high mucopurulent secretion along the upper and lower airways and nasal cavitiy (Figure 1). Bronchoalveolar bacterial cultures were consistent with chronic infections. Reduced ciliary number and rhinitis were observed in nasal mucosa. Affected animals also showed recurrent bacterial infections, abnormal axonemal organization including extra microtubules, and absent/shortened dynein arms.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31479451","rdfs:label":"Naturally occurring Nme5-related canine PCD model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/00efe110-5916-4da0-92ac-cee8c8b18140_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d131114d-8a0f-415d-b95b-1c8da3c16c8f","type":"EvidenceLine","dc:description":"Default scoring is recommended as the patient cells exhibit functional abnormalities relevant to the subtype of PCD caused by radial spoke defects. Ciliary structure and function are shown to be defective.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12da9d28-e874-4319-9721-7f448b77a157","type":"FunctionalAlteration","dc:description":"The cells exhibit axonemal structural abnormalities such as the absence of the central microtubule pair and/or aberrations in the number of peripheral microtubule pairs (Figures 3A, 3B). Ciliary beat frequencies are higher on average and more variable in cells harboring the variant (Figure 4), while mucociliary clearance is impaired (Figure 5).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37296588","rdfs:label":"NME5-deficient patient iPSCs exhibit PCD features."}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/00efe110-5916-4da0-92ac-cee8c8b18140_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a5b66b2-6c00-4d1f-bca6-97080bcf8255","type":"EvidenceLine","dc:description":"No scoring has been recommended as this evidence of a structural role in the radial spoke neck has been previously demonstrated and scored in association with another publication (PMID: 25789548).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28307f9b-d27e-445f-901b-cbabd73c48fe","type":"Finding","dc:description":"NME5 localization to the radial spoke neck is consistent with a role in stabilizing axonemal structure around the central microtubule pair, and may be related to the central pair defects observed in patients harboring NME5 variants.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22065640","rdfs:label":"NME5 localizes to the radial spoke neck.","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/51ca8a6a-2428-4e84-86de-b5b27b285cfa","type":"EvidenceLine","dc:description":"The expression profile of NME5 across multiple human tissues shows high expression in several tissues that contain multi-ciliated cells, consistent of a role in ciliary function and PCD.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7b78d25-becd-40a2-8ff9-580d23ba1a2f","type":"Finding","dc:description":"Human RNA-seq data from the GTEx portal (PMID: 23715323) show high NME5 expression in the testis and to a lesser degree in the fallopian tube and lung. All of these tissues contain multi-ciliated or flagellated cells, consistent with a role for NME5 in ciliary function.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23715323","rdfs:label":"NME5 is highly expressed in multi-ciliated tissues","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c5bfbda3-3206-4a49-b94f-938f7fc3bd75","type":"EvidenceLine","dc:description":"Default scoring has been recommended since multiple other radial spoke head protein-encoding genes have been linked with PCD, yet NME5 is the first such gene to encode a radial spoke head stalk component.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/29d92ba4-b524-4ba9-b17f-a69c61fe1f26","type":"Finding","dc:description":"GST pull-down assays identify recombinant RSP1, RSP4, and RSP9 as a components of the radial spoke head (Figures 2, 3).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21391306","rdfs:label":"Radial spoke head genes are associated with PCD.","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9930d28d-589b-443a-b913-2b6b61157d43","type":"EvidenceLine","dc:description":"Default scoring is considered appropriate as this study adds more detailed functional information to the known association of NME5 with the ciliary axoneme, as previously published (PMID: 12169685).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b25be3d2-213b-43ee-85a3-217ea44f5d87","type":"Finding","dc:description":"The absence of radial spoke head stalk function is associated with the classic PCD phenotypes and the lack of situs inversus exhibited by the affected patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21391306","rdfs:label":"GST pull-downs identify NME5 as radial spoke stalk component","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b91cda82-fc80-4a99-9703-29d11ccc43b0","type":"EvidenceLine","dc:description":"No scoring has been assigned since this data has been collected from a less relevant cell type (sperm flagella), yet it adds some value to previously scored biochemical evidence in that it localizes the NME5 signal to the central microtubule pair in particular.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/62ecff34-7041-4313-9650-38fa06f76795","type":"Finding","dc:description":"Preferential NME5 localization to the central pair is consistent with a role in stabilizing axonemal structure around the central microtubule pair, and may be related to the central pair defects observed in patients harboring NME5 variants.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14499630","rdfs:label":"NME5 associates with central MT pair in sperm flagella.","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5390e7dd-2614-464b-9cd2-3f4db7a07a99","type":"EvidenceLine","dc:description":"Default scoring is considered appropriate based on the experiment establishing a role for NME5 in the airway ciliary axoneme, consistent with PCD features in NME5-deficient human patients.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9201f751-b5e4-43b5-a46e-2c4fc653e5c8","type":"Finding","dc:description":"NME5 protein (referred to here as human nucleoside diphosphate kinase homolog, testis-specific) was repeatedly identified by multiple forms of mass spectrometry as one of the components of the ciliary axoneme from human airway cells (Tables I, II, III).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12169685","rdfs:label":"NME5 is a component of the human airway ciliary axoneme.","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cd84f359-fab3-480e-b2ba-6235f3dd15f4","type":"EvidenceLine","dc:description":"Default scoring is considered appropriate as this finding is complemented by others that similarly link NME5 to the neck region of the ciliary radial spoke complex.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd557061-4abc-4fd2-b05d-22279088a42a","type":"Finding","dc:description":"This role of NME5 in connecting the radial spoke head and radial spoke stalk lends credibility to the loss of NME5 as the cause of abnormal central microtubular pair morphology of respiratory motile cilia.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25789548","rdfs:label":"NME5 localizes to the radial spoke neck.","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Moderate","sequence":8075,"specifiedBy":"GeneValidityCriteria10","strengthScore":9.75,"subject":{"id":"https://genegraph.clinicalgenome.org/r/yV_dcBLNMUQ","type":"GeneValidityProposition","disease":"obo:MONDO_0031054","gene":"hgnc:7853","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_00efe110-5916-4da0-92ac-cee8c8b18140-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}